IonMAN II Trial- Early Feasibility Study of the IoNIR Ridaforolimus-Eluting Coronary Stent System

NCT06071702 · clinicaltrials.gov ↗
NA
Phase
SUSPENDED
Status
30
Enrollment
INDUSTRY
Sponsor class

Stopped Study was not initiated in any site. Sponsor decided not to start the study

Conditions

Interventions

Sponsor

Medinol Ltd.